TMPRSS2 and posterior cortical atrophy: Several published studies have shown that PCa patients with the TMPRSS2-ERG gene fusion conferred a higher risk of recurrence, whereas others reported a significant association with a favorable prognosis or a null relationship with clinical outcome.